Synthetic foldable proteins generated from peptide segments of folding nuclei of reference proteins
US-12583897-B2 · Mar 24, 2026 · US
acidic FGF [aFGF]
acidic FGF [aFGF] · Cooperative Patent Classification (CPC)
Chemical and metallurgical processes, compounds, and materials.
Related technology areas
Mapped technology topics for this CPC code.
| Metric | Value |
|---|---|
| CPC code | C07K14/501 |
| Official title | {acidic FGF [aFGF]} |
| Display label | acidic FGF [aFGF] |
| Total patents | 49 |
Filing trend
Year-over-year patent counts classified under this CPC code.
Filing activity over the last five years is rapidly declining.
| Year | Patents |
|---|---|
| 2015 | 4 |
| 2016 | 4 |
| 2017 | 7 |
| 2018 | 12 |
| 2019 | 7 |
| 2020 | 4 |
| 2021 | 1 |
| 2022 | 4 |
| 2023 | 3 |
| 2024 | 1 |
| 2026 | 2 |
Representative patents
Representative publications under this CPC code from precomputed stats, or recent filings when stats are unavailable.
Cell cultivation processes for preparing food products, products provided by said processes and a system for providing these processes
US-2026049281-A1 · Feb 19, 2026 · US
BACTERIUM MODIFIED TO EXPRESS HETEROLOGOUS Tat PROTEIN
US-2024277783-A1 · Aug 22, 2024 · US
Synthetic foldable proteins generated from peptide segments of folding nuclei of reference proteins
US-2023265142-A1 · Aug 24, 2023 · US
Fibroblast growth factor 1 (fgf1) mutant proteins that selectively activate fgfr1b to reduce blood glucose
US-2023097335-A1 · Mar 30, 2023 · US
Fibroblast growth factor 1 (FGF1) mutant proteins that selectively activate FGFR1B to reduce blood glucose
US-11542309-B2 · Jan 3, 2023 · US
Synthetic foldable proteins generated from peptide segments of folding nuclei of reference proteins
US-11479590-B2 · Oct 25, 2022 · US
Engineered fgf1 and fgf2 compositions and methods of use thereof
US-2022227826-A1 · Jul 21, 2022 · US
Engineered FGF1 and FGF2 compositions and methods of use thereof
US-11267855-B2 · Mar 8, 2022 · US
Dominant-negative FGF2 antagonists
US-11229681-B2 · Jan 25, 2022 · US
Fibroblast growth factor 1 (fgf1) mutant proteins that selectively activate fgfr1b to reduce blood glucose
US-2021032303-A1 · Feb 4, 2021 · US
Chimeric fibroblast growth factor 21 proteins and methods of use
US-10703788-B2 · Jul 7, 2020 · US
Treatment of steroid-induced hyperglycemia with fibroblast growth factor (FGF) 1 analogs
US-10695404-B2 · Jun 30, 2020 · US
Chimeric fibroblast growth factor 19 proteins and methods of use
US-10633424-B2 · Apr 28, 2020 · US
Fibroblast growth factor (fgf) 1 with mutation in the heparin binding domain and methods of use to reduce blood glucose
US-2020040051-A1 · Feb 6, 2020 · US
Engineered fgf1 and fgf2 compositions and methods of use thereof
US-2019284252-A1 · Sep 19, 2019 · US
Use of fibroblast growth factor 1 (fgf1)-vagus nerve targeting chimeric proteins to treat hyperglycemia
US-2019276510-A1 · Sep 12, 2019 · US
Engineered FGF compositions and methods of use thereof
US-10385113-B2 · Aug 20, 2019 · US
Chimeric fibroblast growth factor 23 proteins and methods of use
US-10364278-B2 · Jul 30, 2019 · US
Mutated fibroblast growth factor (fgf) 1 and methods of use
US-2019192630-A1 · Jun 27, 2019 · US
Frequently asked questions
Answers are generated from the same data shown on this page.
- What is CPC C07K14/501?
- CPC C07K14/501 is the Cooperative Patent Classification code for “acidic FGF [aFGF].”
- How many patents are filed under CPC C07K14/501 (acidic FGF [aFGF])?
- Our database includes 49 publications tagged with this CPC code.
- Is patent activity under CPC C07K14/501 growing?
- Publication counts under this code: 3 in 2023 vs 1 in 2024 (latest complete years).